Acadia Pharmaceuticals
ACAD
ACAD
235 hedge funds and large institutions have $3.81B invested in Acadia Pharmaceuticals in 2023 Q2 according to their latest regulatory filings, with 34 funds opening new positions, 76 increasing their positions, 76 reducing their positions, and 29 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
1% more funds holding
Funds holding: 232 → 235 (+3)
0.88% more ownership
Funds ownership: 97% → 97.88% (+0.88%)
0% more repeat investments, than reductions
Existing positions increased: 76 | Existing positions reduced: 76
Holders
235
Holding in Top 10
8
Calls
$12.4M
Puts
$5.54M
Top Buyers
| 1 | +$55.8M | |
| 2 | +$36.9M | |
| 3 | +$35M | |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$22.5M |
| 5 |
BBA
Baker Bros. Advisors
New York
|
+$22.2M |
Top Sellers
| 1 | -$60.5M | |
| 2 | -$31.2M | |
| 3 | -$30.3M | |
| 4 |
Wellington Management Group
Boston,
Massachusetts
|
-$22.2M |
| 5 |
Norges Bank
Oslo,
Norway
|
-$14.2M |